Cas:404-71-7 4-Fluorophenylisocyanate manufacturer & supplier

We serve Chemical Name:4-Fluorophenylisocyanate CAS:404-71-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Fluorophenylisocyanate

Chemical Name:4-Fluorophenylisocyanate
CAS.NO:404-71-7
Synonyms:Benzene, 1-fluoro-4-isocyanato-;3-Fluorophenyl Isocyanate;EINECS 206-966-1;p-Fluorophenyl isocyanate;1-fluoro-3-isocyanatobenzene;MFCD00002015;4-Fluorophenylisocyanate;Isocyanic Acid 3-Fluorophenyl Ester;1-Fluoro-4-isocyanatobenzene
Molecular Formula:C7H4FNO
Molecular Weight:137.111
HS Code:2929109000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:166.9±23.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.505
PSA:29.43000
Exact Mass:137.027695
LogP:2.88

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3080 6.1/PG 2
Packing Group:III


Contact us for information like Benzene, 1-fluoro-4-isocyanato- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Fluoro-4-isocyanatobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 206-966-1 Use and application,MFCD00002015 technical grade,usp/ep/jp grade.


Related News: Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. 4-Fluorophenylisocyanate manufacturer In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. 4-Fluorophenylisocyanate supplier Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. 4-Fluorophenylisocyanate vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. 4-Fluorophenylisocyanate factory Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.